| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | PMS1 ATP6V1E1 DDX12P MYO1D ATP6V1E2 CHD9 SMC2 RAD50 BPTF ACSM4 ATAD3A AFG3L2 AACS CHD6 | 1.95e-05 | 614 | 120 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.19e-04 | 127 | 120 | 6 | GO:0008094 | |
| GeneOntologyBiologicalProcess | vesicle cargo loading | 1.63e-09 | 36 | 123 | 7 | GO:0035459 | |
| GeneOntologyBiologicalProcess | protein secretion | CTAGE9 ILDR2 BRSK2 CTAGE6 PPID CTAGE1 CTAGE8 AACS LRRC8A CTAGE15 GNA11 CTAGE4 | 3.06e-05 | 480 | 123 | 12 | GO:0009306 |
| GeneOntologyBiologicalProcess | establishment of protein localization to extracellular region | CTAGE9 ILDR2 BRSK2 CTAGE6 PPID CTAGE1 CTAGE8 AACS LRRC8A CTAGE15 GNA11 CTAGE4 | 3.25e-05 | 483 | 123 | 12 | GO:0035592 |
| GeneOntologyBiologicalProcess | protein localization to extracellular region | CTAGE9 ILDR2 BRSK2 CTAGE6 PPID CTAGE1 CTAGE8 AACS LRRC8A CTAGE15 GNA11 CTAGE4 | 3.74e-05 | 490 | 123 | 12 | GO:0071692 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization involved in establishment of planar polarity | 1.05e-04 | 3 | 123 | 2 | GO:0090176 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 1.54e-07 | 42 | 122 | 6 | GO:0070971 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.24e-04 | 17 | 122 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | leading edge membrane | 2.36e-04 | 210 | 122 | 7 | GO:0031256 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 3.81e-04 | 378 | 122 | 9 | GO:0034702 | |
| GeneOntologyCellularComponent | sodium channel complex | 6.34e-04 | 29 | 122 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | CTAGE9 ILDR2 RANBP2 NRAS DPY19L1 PSKH1 CTAGE6 SCD5 ANKLE2 LCLAT1 GUCY2C CTAGE1 SLC35D3 CTAGE8 PEX16 CTAGE15 LRRC8B CTAGE4 | 6.86e-04 | 1327 | 122 | 18 | GO:0042175 |
| GeneOntologyCellularComponent | transmembrane transporter complex | GABRE ATP6V1E1 TRPC3 PTPA SCN1A SCN2A CNGB3 SCN7A LRRC8A LRRC8B | 9.95e-04 | 523 | 122 | 10 | GO:1902495 |
| GeneOntologyCellularComponent | T-tubule | 1.18e-03 | 79 | 122 | 4 | GO:0030315 | |
| GeneOntologyCellularComponent | neuron projection membrane | 1.36e-03 | 82 | 122 | 4 | GO:0032589 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | CTAGE9 ILDR2 NRAS DPY19L1 PSKH1 CTAGE6 SCD5 ANKLE2 LCLAT1 GUCY2C CTAGE1 SLC35D3 CTAGE8 PEX16 CTAGE15 LRRC8B CTAGE4 | 1.37e-03 | 1293 | 122 | 17 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | CTAGE9 ILDR2 NRAS DPY19L1 PSKH1 CTAGE6 SCD5 ANKLE2 LCLAT1 GUCY2C CTAGE1 SLC35D3 CTAGE8 PEX16 CTAGE15 LRRC8B CTAGE4 | 1.44e-03 | 1299 | 122 | 17 | GO:0098827 |
| GeneOntologyCellularComponent | transporter complex | GABRE ATP6V1E1 TRPC3 PTPA SCN1A SCN2A CNGB3 SCN7A LRRC8A LRRC8B | 1.45e-03 | 550 | 122 | 10 | GO:1990351 |
| Domain | Na_channel_asu | 2.71e-05 | 10 | 116 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 2.71e-05 | 10 | 116 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 2.71e-05 | 10 | 116 | 3 | PF06512 | |
| Domain | vATP-synt_E | 3.82e-05 | 2 | 116 | 2 | PF01991 | |
| Domain | ATPase_V1/A1-cplx_esu | 3.82e-05 | 2 | 116 | 2 | IPR002842 | |
| Domain | Clathrin_H-chain_linker | 1.14e-04 | 3 | 116 | 2 | IPR012331 | |
| Domain | IQ | 1.49e-04 | 81 | 116 | 5 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 2.45e-04 | 90 | 116 | 5 | IPR000048 | |
| Domain | LRRC8_Pannexin-like | 3.78e-04 | 5 | 116 | 2 | IPR021040 | |
| Domain | Pannexin_like | 3.78e-04 | 5 | 116 | 2 | PF12534 | |
| Domain | BRK | 5.64e-04 | 6 | 116 | 2 | SM00592 | |
| Domain | Na_trans_cytopl | 5.64e-04 | 6 | 116 | 2 | PF11933 | |
| Domain | BRK_domain | 5.64e-04 | 6 | 116 | 2 | IPR006576 | |
| Domain | Na_trans_cytopl | 5.64e-04 | 6 | 116 | 2 | IPR024583 | |
| Domain | BRK | 5.64e-04 | 6 | 116 | 2 | PF07533 | |
| Domain | 7TM_GPCR_Srsx | 6.70e-04 | 112 | 116 | 5 | SM01381 | |
| Domain | Ion_trans_dom | 7.26e-04 | 114 | 116 | 5 | IPR005821 | |
| Domain | Ion_trans | 7.26e-04 | 114 | 116 | 5 | PF00520 | |
| Domain | Chromodomain-like | 1.02e-03 | 32 | 116 | 3 | IPR016197 | |
| Domain | RecF/RecN/SMC_N | 1.04e-03 | 8 | 116 | 2 | IPR003395 | |
| Domain | SMC_N | 1.04e-03 | 8 | 116 | 2 | PF02463 | |
| Domain | Chromo/shadow_dom | 1.11e-03 | 33 | 116 | 3 | IPR000953 | |
| Domain | CHROMO | 1.11e-03 | 33 | 116 | 3 | SM00298 | |
| Domain | Znf_C2H2_matrin | 2.42e-03 | 12 | 116 | 2 | IPR000690 | |
| Domain | IQ | 2.70e-03 | 93 | 116 | 4 | PS50096 | |
| Domain | - | 3.81e-03 | 15 | 116 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 3.81e-03 | 15 | 116 | 2 | SM00501 | |
| Domain | ARID_dom | 3.81e-03 | 15 | 116 | 2 | IPR001606 | |
| Domain | ARID | 3.81e-03 | 15 | 116 | 2 | PS51011 | |
| Domain | ARID | 3.81e-03 | 15 | 116 | 2 | PF01388 | |
| Domain | ARM-type_fold | 5.26e-03 | 339 | 116 | 7 | IPR016024 | |
| Domain | Channel_four-helix_dom | 5.35e-03 | 57 | 116 | 3 | IPR027359 | |
| Domain | - | 5.35e-03 | 57 | 116 | 3 | 1.20.120.350 | |
| Domain | ZF_MATRIN | 5.48e-03 | 18 | 116 | 2 | PS50171 | |
| Domain | Cyclophilin-type_PPIase_CS | 6.10e-03 | 19 | 116 | 2 | IPR020892 | |
| Pubmed | KRT72 RANBP2 MYO1D KRT74 UBR4 ZNF318 CTAGE6 SMC2 ANKLE2 DNTTIP2 BPTF HOOK1 ATAD3A CEP112 CTAGE1 PES1 CTAGE8 CLTC SUPT16H FAM169A CTAGE15 CHD6 CTAGE4 AP3D1 | 2.67e-10 | 1442 | 124 | 24 | 35575683 | |
| Pubmed | PRPSAP1 GPD2 RANBP2 RRP1B UBR4 KRI1 SMC2 LCLAT1 RAD50 ATAD3A PURA PES1 AFG3L2 CNOT7 CLTC SUPT16H SF3A3 IFI44L EIF3C VPS53 AP3D1 CCDC93 | 7.84e-09 | 1440 | 124 | 22 | 30833792 | |
| Pubmed | RANBP2 MYO1D RRP1B UBR4 KRI1 ZNF318 ME2 DNTTIP2 RAD50 BPTF ATAD3A PES1 CLTC SYMPK | 9.62e-08 | 653 | 124 | 14 | 22586326 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | GPD2 RANBP2 MYO1D RRP1B UBR4 KRI1 SMC2 ME2 DNTTIP2 RAD50 JARID2 ATAD3A PES1 CLTC SUPT16H DIAPH1 SF3A3 CSTF1 EIF3C PLCG1 | 1.61e-07 | 1425 | 124 | 20 | 30948266 |
| Pubmed | Mea6 controls VLDL transport through the coordinated regulation of COPII assembly. | 1.76e-07 | 4 | 124 | 3 | 27311593 | |
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 31244610 | ||
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 21807889 | ||
| Pubmed | Deletion of Mea6 in Cerebellar Granule Cells Impairs Synaptic Development and Motor Performance. | 1.76e-07 | 4 | 124 | 3 | 33718348 | |
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 12586826 | ||
| Pubmed | cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing. | 4.40e-07 | 5 | 124 | 3 | 12839582 | |
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 18630941 | ||
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 19131326 | ||
| Pubmed | Characterization and expression pattern of the novel MIA homolog TANGO. | 4.40e-07 | 5 | 124 | 3 | 15183315 | |
| Pubmed | Mea6/cTAGE5 cooperates with TRAPPC12 to regulate PTN secretion and white matter development. | 4.40e-07 | 5 | 124 | 3 | 38439956 | |
| Pubmed | A tissue-specific atlas of mouse protein phosphorylation and expression. | 4.40e-07 | 5 | 124 | 3 | 21183079 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | GPD2 RANBP2 NRAS RRP1B USP28 KRI1 CMSS1 DNTTIP2 RAD50 BPTF PES1 CLTC SUPT16H SF3A3 EIF3C SYMPK | 5.00e-07 | 989 | 124 | 16 | 36424410 |
| Pubmed | RANBP2 RRP1B KRT74 KRI1 SMC2 DNTTIP2 ATAD3A PES1 CLTC SUPT16H SF3A3 EIF3C AP3D1 | 5.31e-07 | 641 | 124 | 13 | 36057605 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | GPD2 RANBP2 MYO1D RRP1B ZNF318 SMC2 DNTTIP2 RAD50 BPTF ATAD3A PES1 AFG3L2 CLTC SUPT16H SF3A3 EIF3C | 7.89e-07 | 1024 | 124 | 16 | 24711643 |
| Pubmed | RANBP2 DPY19L1 SMC2 OLFML3 RAD50 JARID2 BPTF PES1 AFG3L2 SUPT16H CHD6 | 1.03e-06 | 469 | 124 | 11 | 27634302 | |
| Pubmed | cTAGE5 deletion in pancreatic β cells impairs proinsulin trafficking and insulin biogenesis in mice. | 1.53e-06 | 7 | 124 | 3 | 29133483 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | ATP6V1E1 DPYSL3 RRP1B CMSS1 SMC2 RAD50 ATAD3A CTAGE8 CLTC SF3A3 ADAMTS20 EIF3C AP3D1 CCDC93 | 2.12e-06 | 847 | 124 | 14 | 35235311 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | PRPSAP1 GPD2 RANBP2 RRP1B UBR4 KRI1 CMSS1 SMC2 DNTTIP2 RAD50 ATAD3A AFG3L2 CLTC SUPT16H DIAPH1 SF3A3 EIF3C AP3D1 | 2.88e-06 | 1415 | 124 | 18 | 28515276 |
| Pubmed | RANBP2 UBR4 SMC2 RAD50 ATAD3A PES1 CLTC SUPT16H DIAPH1 EIF3C AP3D1 SYMPK | 3.22e-06 | 638 | 124 | 12 | 33239621 | |
| Pubmed | MYO1D RRP1B ARID4A KRT74 UBR4 KRI1 ZNF318 RAD50 BPTF ATAD3A PURA PES1 CNOT7 CSTF1 CEP152 CHD6 EIF3C SYMPK | 3.30e-06 | 1429 | 124 | 18 | 35140242 | |
| Pubmed | RANBP2 USP28 UBR4 POLR2K CHD9 SMC2 PPID RAD50 BPTF PTPA PES1 SUPT16H DIAPH1 CSTF1 SYMPK | 3.49e-06 | 1014 | 124 | 15 | 32416067 | |
| Pubmed | Misexpression of MIA disrupts lung morphogenesis and causes neonatal death. | 3.66e-06 | 9 | 124 | 3 | 18342301 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | RANBP2 RRP1B UBR4 POLR2K KRI1 SMC2 DNTTIP2 ITPK1 ATAD3A PES1 AFG3L2 CLTC SUPT16H DIAPH1 SF3A3 CHD6 AP3D1 | 4.66e-06 | 1318 | 124 | 17 | 30463901 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | RRP1B DPY19L1 BRSK2 SMIM20 DNTTIP2 RAD50 PURA CNGB3 AFG3L2 SUPT16H AKT2 EIF3C PLCG1 BRSK1 | 4.84e-06 | 910 | 124 | 14 | 36736316 |
| Pubmed | Common variants associated with general and MMR vaccine-related febrile seizures. | 5.21e-06 | 10 | 124 | 3 | 25344690 | |
| Pubmed | PMS1 GPD2 RANBP2 DPYSL3 MYO1D RRP1B KRI1 ANKLE2 PTPA PES1 AFG3L2 CLTC SUPT16H EIF3C SYMPK | 5.25e-06 | 1049 | 124 | 15 | 27880917 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 6.19e-06 | 271 | 124 | 8 | 32433965 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | PMS1 RANBP2 DPYSL3 USP28 ZNF318 ME2 DNTTIP2 RAD50 PES1 AFG3L2 FAM169A EIF3C PLCG1 AP3D1 | 6.51e-06 | 934 | 124 | 14 | 33916271 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RANBP2 UBR4 CMSS1 SMC2 DNTTIP2 RAD50 ATAD3A PES1 AFG3L2 CLTC SUPT16H DIAPH1 SF3A3 CSTF1 PLCG1 AP3D1 CCDC93 | 6.57e-06 | 1353 | 124 | 17 | 29467282 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | GPD2 RANBP2 ATP6V1E1 NRAS RRP1B UBR4 SMC2 ME2 PPID RAD50 ATAD3A CLTC SUPT16H SF3A3 GNA11 EIF3C SYMPK | 7.51e-06 | 1367 | 124 | 17 | 32687490 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | GPD2 RANBP2 RRP1B CHD9 BPTF ATAD3A PES1 CLTC SUPT16H SF3A3 CSTF1 CHD6 EIF3C AP3D1 SYMPK | 7.59e-06 | 1082 | 124 | 15 | 38697112 |
| Pubmed | 8.30e-06 | 36 | 124 | 4 | 33230114 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | PITPNM2 RANBP2 UBR4 WASHC3 TUBGCP5 GPR158 LRRC8A LRRC8B CHD6 AP3D1 | 8.37e-06 | 475 | 124 | 10 | 31040226 |
| Pubmed | 9.51e-06 | 12 | 124 | 3 | 23275438 | ||
| Pubmed | RANBP2 RRP1B KRI1 CMSS1 DNTTIP2 ATAD3A PURA PES1 CLTC SUPT16H | 9.68e-06 | 483 | 124 | 10 | 36912080 | |
| Pubmed | RANBP2 RRP1B KRI1 SMC2 DNTTIP2 ATAD3A PURA PES1 SF3A3 CSTF1 LRRC8B EIF3C SYMPK | 1.11e-05 | 847 | 124 | 13 | 35850772 | |
| Pubmed | Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice. | 1.23e-05 | 13 | 124 | 3 | 11839810 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | RANBP2 NRAS ARID4A USP28 UBR4 CHSY1 CMSS1 SMC2 RAD50 BPTF PES1 SF3A3 SYMPK | 1.25e-05 | 857 | 124 | 13 | 25609649 |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 29649454 | ||
| Pubmed | Dissection of RAS downstream pathways in melanomagenesis: a role for Ral in transformation. | 1.26e-05 | 2 | 124 | 2 | 20118982 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 18662668 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 11390650 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 12496421 | ||
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 1.26e-05 | 2 | 124 | 2 | 10827969 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 19694741 | ||
| Pubmed | Phospholipase Cgamma1 controls surface expression of TRPC3 through an intermolecular PH domain. | 1.26e-05 | 2 | 124 | 2 | 15744307 | |
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 1.26e-05 | 2 | 124 | 2 | 1317301 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 33096315 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 31439038 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 16297597 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 26311622 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 16630837 | ||
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 1.26e-05 | 2 | 124 | 2 | 15249644 | |
| Pubmed | A human gene, ATP6E1, encoding a testis-specific isoform of H(+)-ATPase subunit E. | 1.26e-05 | 2 | 124 | 2 | 12036578 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 15766521 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 21377452 | ||
| Pubmed | Dual role of SLP-76 in mediating T cell receptor-induced activation of phospholipase C-gamma1. | 1.26e-05 | 2 | 124 | 2 | 17148460 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 15623534 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 1846440 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 30693367 | ||
| Pubmed | Investigating the regulation of brain-specific kinases 1 and 2 by phosphorylation. | 1.26e-05 | 2 | 124 | 2 | 18339622 | |
| Pubmed | Isozyme-Specific Role of SAD-A in Neuronal Migration During Development of Cerebral Cortex. | 1.26e-05 | 2 | 124 | 2 | 30307479 | |
| Pubmed | GPD2 KRT72 PITPNM2 ILDR2 ATP6V1E1 DPYSL3 MYO1D BRSK2 FGD4 ATAD3A PURA SCN2A AFG3L2 CLTC EIF3C BRSK1 AP3D1 | 1.36e-05 | 1431 | 124 | 17 | 37142655 | |
| Pubmed | PITPNM2 RANBP2 UBR4 BRSK2 SCD5 ANKLE2 GPR158 ATAD3A SCN1A PURA AFG3L2 CLTC FAM169A AKT2 EIF3C | 1.39e-05 | 1139 | 124 | 15 | 36417873 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 1.73e-05 | 410 | 124 | 9 | 26949251 | |
| Pubmed | Confirmation of quantitative trait loci for alcohol preference in mice. | 1.95e-05 | 15 | 124 | 3 | 9726281 | |
| Pubmed | cTAGE5/MEA6 plays a critical role in neuronal cellular components trafficking and brain development. | 1.95e-05 | 15 | 124 | 3 | 30224460 | |
| Pubmed | 2.20e-05 | 323 | 124 | 8 | 24797263 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | PRPSAP1 RALGDS CMSS1 ITPK1 JARID2 BPTF TENM3 LRRC8A CEP152 SYMPK | 2.36e-05 | 536 | 124 | 10 | 15840001 |
| Pubmed | 2.39e-05 | 237 | 124 | 7 | 29564676 | ||
| Pubmed | PRPSAP1 RALGDS CMSS1 ITPK1 JARID2 BPTF TENM3 LRRC8A CEP152 SYMPK | 2.44e-05 | 538 | 124 | 10 | 10512203 | |
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | 2.50e-05 | 329 | 124 | 8 | 34316702 | |
| Pubmed | RANBP2 ATP6V1E1 RRP1B DNTTIP2 ATAD3A PES1 CLTC SUPT16H CSTF1 GNA11 EIF3C | 2.58e-05 | 660 | 124 | 11 | 32780723 | |
| Pubmed | 2.64e-05 | 162 | 124 | 6 | 15174051 | ||
| Pubmed | 3.05e-05 | 100 | 124 | 5 | 10048485 | ||
| Pubmed | RIPOR2 RALGPS2 WASHC3 ZNF318 SCD5 ANKLE2 ME2 DNTTIP2 LCLAT1 CEP112 CLTC DIAPH1 GNA11 PLCG1 | 3.39e-05 | 1084 | 124 | 14 | 11544199 | |
| Pubmed | 3.42e-05 | 560 | 124 | 10 | 35241646 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 28784306 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 32185219 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 12610651 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 32005694 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 26272610 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 23859570 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 22669945 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 18784617 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 17544618 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 20026642 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 33097673 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 22758774 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 32845893 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 28644030 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 28518218 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 19270815 | ||
| Pubmed | Microtubule stabilization specifies initial neuronal polarization. | 3.77e-05 | 3 | 124 | 2 | 18268107 | |
| Pubmed | A proton pump ATPase with testis-specific E1-subunit isoform required for acrosome acidification. | 3.77e-05 | 3 | 124 | 2 | 11872743 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 25155934 | ||
| Interaction | CTAGE1 interactions | 1.92e-09 | 10 | 123 | 5 | int:CTAGE1 | |
| Cytoband | 7q35 | 1.55e-05 | 55 | 124 | 4 | 7q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q35 | 3.21e-05 | 66 | 124 | 4 | chr7q35 | |
| Cytoband | 5q31 | 2.78e-04 | 115 | 124 | 4 | 5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 4.05e-04 | 127 | 124 | 4 | chr2q24 | |
| Cytoband | 2q24.3 | 8.47e-04 | 16 | 124 | 2 | 2q24.3 | |
| GeneFamily | CTAGE family | 3.50e-11 | 15 | 82 | 6 | 907 | |
| GeneFamily | Cyclophilin peptidylprolyl isomerases | 8.27e-05 | 19 | 82 | 3 | 909 | |
| GeneFamily | Volume regulated anion channel subunits | 2.01e-04 | 5 | 82 | 2 | 1158 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 7.17e-04 | 9 | 82 | 2 | 1203 | |
| GeneFamily | AT-rich interaction domain containing | 2.05e-03 | 15 | 82 | 2 | 418 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.45e-03 | 206 | 82 | 5 | 682 | |
| GeneFamily | V-type ATPases | 4.83e-03 | 23 | 82 | 2 | 415 | |
| GeneFamily | Acyl-CoA synthetase family | 6.15e-03 | 26 | 82 | 2 | 40 | |
| GeneFamily | Keratins, type II | 6.63e-03 | 27 | 82 | 2 | 609 | |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_UP | 1.18e-05 | 162 | 123 | 7 | M8883 | |
| Coexpression | GSE13946_CTRL_VS_DSS_COLITIS_GD_TCELL_FROM_COLON_DN | 1.61e-05 | 170 | 123 | 7 | M2942 | |
| Coexpression | GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_UP | 1.67e-05 | 171 | 123 | 7 | M2947 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.09e-06 | 173 | 124 | 6 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-05 | 177 | 124 | 6 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-05 | 177 | 124 | 6 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | COPD-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 1.29e-05 | 184 | 124 | 6 | ceec41ed5636032aaf7716d1203816ea58bd39bd | |
| ToppCell | Control-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 1.46e-05 | 188 | 124 | 6 | 47126c371a242c937499fd278a74a882df8f759c | |
| ToppCell | IPF-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 1.55e-05 | 190 | 124 | 6 | ffa890138394f579fee53fcfac6c121bf86adc26 | |
| ToppCell | IPF-Myeloid-cMonocyte|IPF / Disease state, Lineage and Cell class | 1.55e-05 | 190 | 124 | 6 | a099f51f2b7618b6712af38eedd5ee64d8663a4a | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.64e-05 | 192 | 124 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | Control-Myeloid-cMonocyte|Control / Disease state, Lineage and Cell class | 1.64e-05 | 192 | 124 | 6 | ad04c9c4bdebf94615cee1904ca48197e62c923b | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.69e-05 | 193 | 124 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | COPD-Myeloid-Macrophage|World / Disease state, Lineage and Cell class | 1.74e-05 | 194 | 124 | 6 | 7d682408e9a6239a4e47befc9376e760cc3d133a | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-CFuPNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.79e-05 | 195 | 124 | 6 | 574354ef4bcefeb9856b65d19bb92e2cffe5dc7a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-05 | 196 | 124 | 6 | f068ce40bf35021baf1468ae9ce30a92162eb14d | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-05 | 197 | 124 | 6 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.07e-05 | 200 | 124 | 6 | e504570fd7eec1524c401b1cfa9d10822d80d994 | |
| ToppCell | (5)_Fibroblasts|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.07e-05 | 200 | 124 | 6 | 22c839f27d3abdf86bfabdfa305f205dd899a9dc | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 2.07e-05 | 200 | 124 | 6 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Fibroblast|World / shred by cell class for parenchyma | 2.07e-05 | 200 | 124 | 6 | dec9ce1bc2571197003596f32e5f742ede72aa79 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.38e-05 | 70 | 124 | 4 | 986c7a1002a4ffd3a246495bedde2997ffdc2c9d | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P3-Tnr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.38e-05 | 70 | 124 | 4 | c0330216305491d7d57cdbea0ae3cb8e9092c8e3 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P3|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.38e-05 | 70 | 124 | 4 | 86dde790fcdaec2095e2256463953077811145d2 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.38e-05 | 70 | 124 | 4 | e604660b2efbc03e21806dcaecf7a72321673ae2 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.55e-05 | 160 | 124 | 5 | 5d8d97c3da5837ba5fe743d2f8438f5cb7cea64b | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.81e-05 | 161 | 124 | 5 | f470b662566131dfe69a2fd01186ac8491196396 | |
| ToppCell | Healthy_Control-Lymphoid-B-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 9.33e-05 | 163 | 124 | 5 | d84bd41b4494c7d5c7f88d511bfe481fb12f079d | |
| ToppCell | Healthy_Control-Lymphoid-B|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 9.33e-05 | 163 | 124 | 5 | 0f723ec2503afa1b3ebb0754972438ffb6e6179d | |
| ToppCell | COVID-19_Mild-PLT_2|World / Disease Group and Platelet Clusters | 1.11e-04 | 169 | 124 | 5 | 6abfdc8b437f19c03b408bedc245059d28c6ba6a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-04 | 174 | 124 | 5 | ebe6ce173ad12d4a2afa39f8d6185c0e4f97fb1e | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.34e-04 | 176 | 124 | 5 | ad05dd934f4ac2e656b3455de091f4c8772de6c8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_TMEM233|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.45e-04 | 179 | 124 | 5 | 747a32460b257fffca30527b56a74720eb9c12e4 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.49e-04 | 180 | 124 | 5 | 81d60f0fa9e3b5bfcec85139a0a49e9130145f0e | |
| ToppCell | LPS-IL1RA-Myeloid-Neutrophils-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-04 | 180 | 124 | 5 | c0c07937839652e01df10cc1e70aa005800ea6f6 | |
| ToppCell | LPS-IL1RA-Myeloid-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-04 | 180 | 124 | 5 | 079c199425dd3c220f03c6dca1823946f07580a1 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.56e-04 | 182 | 124 | 5 | 243c783675df495ea4112dbf710712c44ea6b4f1 | |
| ToppCell | LPS_only-Myeloid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.56e-04 | 182 | 124 | 5 | 666ac86ee5f6fa9241ae8d80340743707e54b278 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.56e-04 | 182 | 124 | 5 | 18790a394dc32b3cef99cdbf826392c520e38b4a | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.65e-04 | 184 | 124 | 5 | 55dde9c4eebac2a33788c1ff1d8fe312d150fad4 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.65e-04 | 184 | 124 | 5 | 7128a2be291544d3df3ed6c80f21ddda8437dcba | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.65e-04 | 184 | 124 | 5 | d14238f7b0b55a4c8d7040bea854bd221a66ac30 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 1.65e-04 | 184 | 124 | 5 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | LPS-IL1RA-Myeloid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.69e-04 | 185 | 124 | 5 | 9b5fd87ea9d05e051ff1251578ecfbe5e8652853 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.73e-04 | 186 | 124 | 5 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | CF|World / Disease state, Lineage and Cell class | 1.77e-04 | 187 | 124 | 5 | eec4d4e4a658e3a61c05745167a1a5e3d39bb43e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-04 | 188 | 124 | 5 | e751cff2ac8fbc1487766c1871fcc5d1005286b0 | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 188 | 124 | 5 | 921a2c9212a0f2a00fd72c594d80924f27e8b9b7 | |
| ToppCell | COPD-Myeloid-cMonocyte|COPD / Disease state, Lineage and Cell class | 1.86e-04 | 189 | 124 | 5 | d29f3a0bd23e6eb46389e6eb7ef21851c7b57545 | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.86e-04 | 189 | 124 | 5 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-04 | 189 | 124 | 5 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.86e-04 | 189 | 124 | 5 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | COPD-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 1.86e-04 | 189 | 124 | 5 | 6294691231c7d38707323cf31578a107d3b2c622 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-04 | 189 | 124 | 5 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.86e-04 | 189 | 124 | 5 | e2bb5900d210386b7b74938e7a3636d0c7ba1bcf | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.86e-04 | 189 | 124 | 5 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-04 | 189 | 124 | 5 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-04 | 189 | 124 | 5 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.91e-04 | 190 | 124 | 5 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.91e-04 | 190 | 124 | 5 | 4d401b73c0e7eb38e95d0851a128bf12bb0d3a9f | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.91e-04 | 190 | 124 | 5 | a7498fe55b7810c482291db782dc5282675d246a | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 1.96e-04 | 191 | 124 | 5 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-04 | 191 | 124 | 5 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.01e-04 | 192 | 124 | 5 | 63d1b3efe93e5ff939278ebe40bacb38218ea09b | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.01e-04 | 192 | 124 | 5 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-CFuPNs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.01e-04 | 192 | 124 | 5 | a8841ebd879f1c344ab4246fdef77044170f644d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.01e-04 | 192 | 124 | 5 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.05e-04 | 193 | 124 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.05e-04 | 193 | 124 | 5 | 5bee7abc550ddaa28cbb3b9ecaf6b924ab175de0 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.05e-04 | 193 | 124 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.05e-04 | 193 | 124 | 5 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | distal-Hematologic-B_cell-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.05e-04 | 193 | 124 | 5 | 202dc5ec2437602c15658074728c5f5aeeab0466 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.10e-04 | 194 | 124 | 5 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | Control-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 2.10e-04 | 194 | 124 | 5 | f852f5258617a66a4fbd56d64c7b47272e7b8b60 | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 2.10e-04 | 194 | 124 | 5 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.15e-04 | 195 | 124 | 5 | 481989d2e5bd2582da3d86b0155c4d6615317067 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.15e-04 | 195 | 124 | 5 | 23ab7e2a419377c05bab0e92a2457afbcd3d9e07 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.15e-04 | 195 | 124 | 5 | 6108a27523d1b93a7fbe35cb95704a5ad9071e3c | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.15e-04 | 195 | 124 | 5 | f08e41706680881ebd0afcd08a02f8ac0089f04e | |
| ToppCell | Control-Myeloid-ncMonocyte|Control / Disease state, Lineage and Cell class | 2.15e-04 | 195 | 124 | 5 | fcb05948e7480dc53f06f3fc9b9c3fc129874edd | |
| ToppCell | mild-B_cell|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.15e-04 | 195 | 124 | 5 | 1e5f1967bcc898318f4e970b844b4a944eb168e5 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.15e-04 | 195 | 124 | 5 | e87b11e3242fdbed2e7f383e6876ec375af32bd4 | |
| ToppCell | Control-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 2.15e-04 | 195 | 124 | 5 | b4444b67a709e82b8e2ee510924c3152cb88b051 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 195 | 124 | 5 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 2.21e-04 | 196 | 124 | 5 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | Control-Neu_4|Control / 5 Neutrophil clusters in COVID-19 patients | 2.21e-04 | 196 | 124 | 5 | b8b7b54ca17a08fa775507bb22b1c7248ada8f40 | |
| ToppCell | COVID-19-Myeloid-Monocytes|COVID-19 / group, cell type (main and fine annotations) | 2.21e-04 | 196 | 124 | 5 | 04d710267658ea5601ae2cfb4ed5acb8a29bd8a1 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.21e-04 | 196 | 124 | 5 | 547901c7a665770eff78eede69b8625b416c8186 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-04 | 196 | 124 | 5 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-04 | 196 | 124 | 5 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 2.21e-04 | 196 | 124 | 5 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-04 | 196 | 124 | 5 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.21e-04 | 196 | 124 | 5 | 6e08d7ba67da161c2dca1a17c440ffb9d9b5bc3b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.21e-04 | 196 | 124 | 5 | e54c08f88779f9fd453a4f5b85aed1f460d8a1e1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.26e-04 | 197 | 124 | 5 | b597c292fc1cb381a4325fed15a32966c38def28 | |
| ToppCell | COVID-19-kidney-Macrophages|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.26e-04 | 197 | 124 | 5 | 3912301018d0863144dcfac8d1fa8adc081748d7 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 2.26e-04 | 197 | 124 | 5 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.26e-04 | 197 | 124 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-04 | 197 | 124 | 5 | 7b12f9d4ad1e84df58e86591a491c84d4f36eac5 | |
| ToppCell | B_cells-Activate_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 2.31e-04 | 198 | 124 | 5 | a663082d7fbd6db11d3d3024bbb8ba00183e19f8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-04 | 198 | 124 | 5 | 97ae237f955fd5fbd01d06aafe89ef9e6f777a9a | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 2.31e-04 | 198 | 124 | 5 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 2.37e-04 | 199 | 124 | 5 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 6.96e-06 | 10 | 116 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 6.96e-06 | 10 | 116 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.27e-05 | 12 | 116 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | MMR-related febrile seizures | 2.60e-05 | 15 | 116 | 3 | EFO_0006519 | |
| Disease | serine/threonine-protein kinase BRSK2 measurement | 4.58e-05 | 3 | 116 | 2 | EFO_0803063 | |
| Disease | antiphospholipid antibody measurement | 1.28e-04 | 25 | 116 | 3 | EFO_0005200 | |
| Disease | brain connectivity measurement | 1.89e-04 | 400 | 116 | 8 | EFO_0005210 | |
| Disease | Inflammatory Myofibroblastic Tumor | 2.27e-04 | 6 | 116 | 2 | C0334121 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 3.18e-04 | 7 | 116 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | Seizure, Febrile, Simple | 3.18e-04 | 7 | 116 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 3.18e-04 | 7 | 116 | 2 | C0751057 | |
| Disease | Intellectual Disability | 3.98e-04 | 447 | 116 | 8 | C3714756 | |
| Disease | Neurodevelopmental Disorders | 5.06e-04 | 93 | 116 | 4 | C1535926 | |
| Disease | Febrile Convulsions | 5.42e-04 | 9 | 116 | 2 | C0009952 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 5.42e-04 | 9 | 116 | 2 | C3502809 | |
| Disease | Bipolar Disorder | 6.09e-04 | 477 | 116 | 8 | C0005586 | |
| Disease | waist-hip ratio | AMPD3 ARID4A ZNF318 SMIM20 CMSS1 LCP2 ADORA1 BPTF FAM13A SCN2A ADAMTS20 AP3D1 SYMPK | 1.08e-03 | 1226 | 116 | 13 | EFO_0004343 |
| Disease | Infantile Severe Myoclonic Epilepsy | 1.16e-03 | 13 | 116 | 2 | C0751122 | |
| Disease | plasminogen activator inhibitor 1 measurement | 1.27e-03 | 54 | 116 | 3 | EFO_0004792 | |
| Disease | ferritin measurement | 1.27e-03 | 119 | 116 | 4 | EFO_0004459 | |
| Disease | cortical thickness | IL34 PITPNM2 RIPOR2 RALGPS2 CHSY1 ZNF318 ME2 PPID CEP112 MACROD2 ADAMTS20 MYO16 | 1.47e-03 | 1113 | 116 | 12 | EFO_0004840 |
| Disease | idiopathic pulmonary fibrosis | 1.48e-03 | 57 | 116 | 3 | EFO_0000768 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 1.77e-03 | 16 | 116 | 2 | C0393706 | |
| Disease | Global developmental delay | 1.91e-03 | 133 | 116 | 4 | C0557874 | |
| Disease | angiopoietin-related protein 1 measurement | 2.25e-03 | 18 | 116 | 2 | EFO_0801382 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 2.25e-03 | 18 | 116 | 2 | HP_0002373 | |
| Disease | Manic Disorder | 2.79e-03 | 71 | 116 | 3 | C0024713 | |
| Disease | neutrophil percentage of leukocytes | 2.87e-03 | 610 | 116 | 8 | EFO_0007990 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.10e-03 | 152 | 116 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Autosomal Recessive Primary Microcephaly | 3.36e-03 | 22 | 116 | 2 | C3711387 | |
| Disease | anxiety disorder (implicated_via_orthology) | 3.36e-03 | 22 | 116 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | Manic | 3.63e-03 | 78 | 116 | 3 | C0338831 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RYYAMKILRKEVIIA | 176 | P31751 | |
| DRYRIYKAQKLREML | 141 | A6H8Y1 | |
| MLQKRIRYVVDLYLN | 391 | Q86XL3 | |
| ETARKMRKYYLICLQ | 1306 | O94986 | |
| EKLQEIRKYYMSLKS | 1191 | P29374 | |
| TELYQENEMKLYRKL | 356 | Q96RT6 | |
| YQENEMKLYRKLTVE | 391 | Q8IX94 | |
| MKLYRKLTVEENYRI | 396 | Q8IX94 | |
| YQEDEMKLYRKLTVE | 391 | Q86UF2 | |
| MKLYRKLTVEENYRI | 396 | Q86UF2 | |
| YQENEMKLYRKLTVE | 391 | P0CG41 | |
| MKLYRKLTVEENYRI | 396 | P0CG41 | |
| YQENEMKLYRKLTVE | 391 | A4FU28 | |
| MKLYRKLTVEENYRI | 396 | A4FU28 | |
| YQENEMKLYRKLTVE | 391 | A4D2H0 | |
| MKLYRKLTVEENYRI | 396 | A4D2H0 | |
| YLRVKIPLRYKMVVT | 106 | P30542 | |
| MVLIYLEVFYLIRKQ | 196 | P30542 | |
| NKYREERVILFLKMA | 576 | Q86V21 | |
| KEQYLYTKEQLLDRM | 611 | Q9Y4W6 | |
| YDEIKRFIRQEIIKM | 1436 | Q07092 | |
| RLVRMYFDKYVLKPA | 531 | Q9NVI7 | |
| DYVYKRIKARRKMAD | 476 | Q14195 | |
| TYIRQEYETKLKGLM | 901 | Q8N8E3 | |
| QKLMKDYYSSRRLVI | 96 | Q9BQ75 | |
| VMYCRVYIVAKRTTK | 221 | P35368 | |
| PTVYRMLVQKDLKRY | 321 | P0C7M7 | |
| LKMATRYRELEVKYA | 166 | O95841 | |
| KYKRLRSMTDVYLLN | 66 | P51679 | |
| DKMSRKVRYYRLKTA | 196 | Q9ULG3 | |
| KDIIIKREMVSQYLY | 116 | O60610 | |
| TMEERVQRRYYEKLT | 2976 | Q12830 | |
| KKRLISYPRYIEIMV | 251 | P59510 | |
| AKALMIREKYARLAY | 156 | Q01432 | |
| YIRKKAVLIMYKVFL | 161 | O14617 | |
| FYTLVREIRQYRMKK | 156 | P01111 | |
| KNYYRILMRRDQVFK | 2966 | P49792 | |
| SDKRRNYNYRVVMLK | 1176 | Q92878 | |
| LLMLRKYRKDYELRQ | 451 | P25092 | |
| YQIVYKLEMRKKEEE | 391 | Q9NRN5 | |
| YRLYMRQTIIKVIKF | 261 | Q8IWT6 | |
| YLQKAIMKLDIEQYR | 121 | P43304 | |
| RSKSYELIRKIEAYM | 106 | Q13572 | |
| KAEMLESVIKNYKRY | 131 | P43362 | |
| VISVLYYLMALRLKK | 231 | Q9GZQ4 | |
| KRMRCEQIKAYYERE | 21 | Q9Y6X6 | |
| LYAQLEIYKRKKMIT | 721 | Q5T848 | |
| YLDKMITRNLKLRFY | 131 | Q53G44 | |
| KPLYDRYRLVKQMLT | 736 | Q9NYF5 | |
| LMRYSYLRLEKICLK | 136 | Q6UWP7 | |
| RQPYAIKMIETKYRE | 121 | P11801 | |
| KMIYFLLLDRKERYP | 331 | Q8IWQ3 | |
| IYTVRNKDVKYSMRK | 286 | Q96R72 | |
| RIPRYEMLLKDYLRK | 351 | Q96M96 | |
| LRARTKIVYSMYSRK | 581 | Q2PZI1 | |
| RPMYLKDYERKVILE | 111 | Q8N9T8 | |
| LMQTLKKDYRLVEYL | 706 | Q96RT8 | |
| KKDYRLVEYLQAMRN | 711 | Q96RT8 | |
| RIYKDGKVLYTIRMT | 176 | P78334 | |
| EYRIAQLYMIQKKSR | 16 | Q9BZ72 | |
| MKPLYDRYRLVKQIL | 831 | O94988 | |
| MHVEQKDIIYRVYLK | 246 | Q6P9F7 | |
| VLMERLCKYIYAKDR | 546 | Q99613 | |
| IDYKSYMDTKLLVAR | 326 | Q15884 | |
| MSEQRLYYIDLKKSR | 216 | A4D1B5 | |
| RYNMEKEKLYKIRLL | 456 | Q567U6 | |
| KIRQVIRKYNYVAMD | 26 | Q9UIV1 | |
| KVLLRVRMLYYLKQE | 1626 | Q3L8U1 | |
| LRDKLQYRSRLQYMK | 41 | Q6ZMJ4 | |
| CNKVLLRVRMLYYLK | 1226 | Q8TD26 | |
| EKKAIYERCSRRNMY | 71 | P0C843 | |
| IRAMETLKILYKYEQ | 91 | P29992 | |
| LLQYMERYGKRLKAK | 441 | Q92771 | |
| QEKMIYYLLLDRKER | 346 | Q8TDC3 | |
| LYVLNRIIYRKQEME | 116 | Q9Y6X4 | |
| MKDYLYGRLINFEKR | 581 | Q12967 | |
| KYIYIMGIQERNEKL | 81 | P23368 | |
| ILKERGAYKIYVMAT | 271 | Q14558 | |
| YKMYLEKARNVIKTL | 606 | Q9UJC3 | |
| YDALQKKYLRMVVLA | 86 | Q86X24 | |
| MYRTKVGLKDRQQLY | 1 | Q05048 | |
| YLSKEDIQDIIYRMK | 891 | P54277 | |
| VMSKEDNYKRLRDYI | 176 | Q86X27 | |
| DNYKRLRDYISSLKM | 181 | Q86X27 | |
| RGLKLMYRYDEEQII | 1176 | Q92833 | |
| MTLEERRKEYLRDYI | 21 | A1Z1Q3 | |
| MEKLRLLGLRYQEYV | 1 | Q9Y5Y5 | |
| VRGTRYMKKDYLIEN | 396 | Q5M8T2 | |
| KYYMLIRLVLRQSFE | 116 | Q14684 | |
| KDEGLQYLERLYMKR | 36 | Q86X40 | |
| MAIKKYAEVLRYVDS | 241 | Q08752 | |
| YFRPLMRLEEYKKEQ | 26 | Q8N5G0 | |
| RIQRKYYKISVVLMC | 186 | Q86SK9 | |
| DILRLIKELAKYEYM | 16 | P21673 | |
| LRELYQEKKVYCPRM | 561 | Q6P1J6 | |
| MAVTLDKDAYYRRVK | 1 | Q9Y5B9 | |
| NTLVIYVILRYAKMK | 61 | P30874 | |
| YVILRYAKMKTITNI | 66 | P30874 | |
| YDLDKQIKTIERYMR | 116 | Q9Y4F9 | |
| YIDQRKTIKTMLEYA | 1241 | P35498 | |
| YLQMARKKARESYVE | 1156 | Q00610 | |
| AKQVELMRDYRIKYP | 581 | Q86X52 | |
| YYRKRTIQLEAKMRI | 111 | Q8NHS4 | |
| LESIMDKAYIYRVIR | 341 | Q9NQW8 | |
| RYNRRKYSEIMAEKA | 726 | Q5QJE6 | |
| EADEYYRKKLLIQMK | 131 | I1YAP6 | |
| YLYQKIMFGKRRKIR | 546 | O00541 | |
| RDSMKVLYYVEKELA | 306 | Q71H61 | |
| NRYLEVMRKLQKTYR | 221 | Q15257 | |
| YIEQRKTIKTMLEYA | 1231 | Q99250 | |
| LYRKMKLRYPINEEA | 746 | P19174 | |
| RIKEIQYEIFRSLMY | 2086 | Q9P273 | |
| YRIMYKKRTKRLVVF | 41 | P53803 | |
| RYMYRSKELIRNKRE | 396 | Q96RU2 | |
| IKRQLVDYEEKYGRM | 291 | Q5VIR6 | |
| RVVKLMYKNRLYFRS | 1086 | Q9ULM0 | |
| KEERSSYLEYQKVMR | 211 | O95347 | |
| IKRMYEKEQLREYVE | 736 | Q92797 | |
| RKLYKEVMLETFRNL | 46 | Q9UC07 | |
| IYMDQRKTIKILLEY | 956 | Q01118 | |
| ERKNAEYKRYLEMLL | 176 | Q12874 | |
| VQTQRLKIMEYYEKK | 46 | P36543 | |
| KLYEFRRGMKRYVTI | 221 | Q5MNZ9 | |
| MLAIQIKYDDYKIRL | 221 | Q6PP77 | |
| LKRTKMVRTINLYYN | 3581 | Q5T4S7 | |
| AKDPRYARYLKMVQV | 131 | Q9Y3C0 | |
| EFLVRENRKYYMDLK | 146 | Q00577 | |
| DREARQKKMYYLRTE | 901 | Q5VUA4 | |
| YRKVMLENYRSLVSL | 31 | Q96ND8 | |
| TRYQQIMKRLIKRYV | 761 | Q13507 | |
| VQTQRLKIMEYYEKK | 46 | Q96A05 | |
| LRNMQDLVEDYKKRY | 201 | Q14CN4 | |
| LRSMRDLVEDYKKRY | 216 | Q7RTS7 | |
| LMVLYKDKVYNIQIR | 461 | Q13094 | |
| MRYKRTKAALTIIRY | 716 | O94832 |